Experimental drug may lead to simpler treatment of macular degeneration

An experimental drug being developed by researchers at Johns Hopkins University is showing promise for simplifying the treatment of age-related macular degeneration. The drug, currently called AXT107, has only been tested in rabbits and mice so far, but the results are encouraging. Professor of ophthalmology, Dr. Peter Campochiaro, anticipates that the effects of the drug … Continue reading Experimental drug may lead to simpler treatment of macular degeneration